MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Brings biopharmaceutical industry closer to digitally-enabled manufacturing facility of the future
MAST® Platform provides real-time process information; cuts process development time by half, improving efficiency and lowering costs
Burlington, MA, April 5, 2022 – MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced the acquisition of MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. The MAST® platform was developed in Bend, Oregon. The financial details of the deal were not disclosed. ... Read more